These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 2772076

  • 21. Combined therapeutic trial in multiple sclerosis: hydrocortisone hemisuccinate with cyclophosphamide or cytosine arabinoside.
    Cendrowski W.
    Acta Neurol Belg; 1973; 73(4):209-19. PubMed ID: 4770124
    [No Abstract] [Full Text] [Related]

  • 22. Azathioprine and methotrexate in multiple sclerosis.
    Fernández O, Fernández V, De Ramón E.
    J Neurol Sci; 2004 Aug 15; 223(1):29-34. PubMed ID: 15261557
    [Abstract] [Full Text] [Related]

  • 23. [Cyclophosphamide changes oligoclonal immunoglobulin G spectrum in cerebrospinal fluid in slowly progressing multiple sclerosis].
    Ochudło S, Wajgt A.
    Neurol Neurochir Pol; 1996 Aug 15; 30(1):7-16. PubMed ID: 8657352
    [Abstract] [Full Text] [Related]

  • 24. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
    Stuart WH.
    Curr Med Res Opin; 2007 Jun 15; 23(6):1199-208. PubMed ID: 17559719
    [Abstract] [Full Text] [Related]

  • 25. Intrathecal immunoglobulin synthesis in multiple sclerosis: effect of corticosteroids and azathioprine.
    Miró J, Aguayo F, Garrido JC, Alvarez C, Polo JM, Pascual J, Berciano J.
    Eur Neurol; 1992 Jun 15; 32(6):349-53. PubMed ID: 1337041
    [Abstract] [Full Text] [Related]

  • 26. [Comments on the contribution, "Immunomodulating staged therapy of multiple sclerosis by the Multiple Sclerosis Therapy Consensus Group"].
    Störh M.
    Nervenarzt; 2002 Dec 15; 73(12):1207; author reply 1207. PubMed ID: 12599336
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].
    Lhermitte F, Marteau R, Roullet E, de Saxcé H, Loridan M.
    Rev Neurol (Paris); 1984 Dec 15; 140(10):553-8. PubMed ID: 6438761
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Double-blind, controlled trial of immunosuppression in treatment of multiple sclerosis.
    Mertin J, Knight SC, Rudge P, Thompson EJ, Healy MJ.
    Lancet; 1980 Nov 01; 2(8201):949-51. PubMed ID: 6107592
    [Abstract] [Full Text] [Related]

  • 33. [Treatment of multiple sclerosis using immunosuppression. Critical discussion of results].
    Hommes OR.
    Ned Tijdschr Geneeskd; 1976 Mar 06; 120(10):424-30. PubMed ID: 765862
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Intrathecal IgG synthesis and IgG index after intensive and chronic immunosuppressive treatment of multiple sclerosis.
    Hommes OR, Lamers KJ, van Geel W.
    Ann N Y Acad Sci; 1984 Mar 06; 436():410-7. PubMed ID: 6598019
    [No Abstract] [Full Text] [Related]

  • 36. [Changes in the clinical and immunological indices of patients with disseminated sclerosis being treated with prednisolone].
    Iarosh AA, Tiazhkorob AM, Prokopiv MM, Kanevskaia SA, Zhovnir IK.
    Vrach Delo; 1991 Dec 06; (12):61-3. PubMed ID: 1792777
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [The effect of prednisolone on the immunoglobulin content of the blood in patients with disseminated sclerosis].
    Iarosh AA, Prokopiv MM, Zhovnir IK, Kanevskaia SA.
    Vrach Delo; 1990 Aug 06; (8):70-2. PubMed ID: 2256298
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.